ATIR101

DB18650InvestigationalCell transplant therapies

ATIR101 is a haploidentical, naïve cell-enriched T-cell therapy.

Code names
ATIR-101 · ATIR-201

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of ATIR101, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In